Logo image of HZO

MARINEMAX INC (HZO) Stock Fundamental Analysis

USA - NYSE:HZO - US5679081084 - Common Stock

25.52 USD
-0.45 (-1.73%)
Last: 10/17/2025, 8:18:56 PM
25.52 USD
0 (0%)
After Hours: 10/17/2025, 8:18:56 PM
Fundamental Rating

3

Taking everything into account, HZO scores 3 out of 10 in our fundamental rating. HZO was compared to 120 industry peers in the Specialty Retail industry. While HZO is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, HZO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year HZO was profitable.
In the past year HZO had a positive cash flow from operations.
In the past 5 years HZO has always been profitable.
In multiple years HZO reported negative operating cash flow during the last 5 years.
HZO Yearly Net Income VS EBIT VS OCF VS FCFHZO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

HZO has a Return On Assets (-1.08%) which is in line with its industry peers.
HZO's Return On Equity of -2.85% is in line compared to the rest of the industry. HZO outperforms 47.50% of its industry peers.
The Return On Invested Capital of HZO (3.78%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for HZO is below the industry average of 12.17%.
The last Return On Invested Capital (3.78%) for HZO is well below the 3 year average (9.69%), which needs to be investigated, but indicates that HZO had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.08%
ROE -2.85%
ROIC 3.78%
ROA(3y)6.87%
ROA(5y)9.12%
ROE(3y)13.71%
ROE(5y)16.71%
ROIC(3y)9.69%
ROIC(5y)12.16%
HZO Yearly ROA, ROE, ROICHZO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

HZO's Profit Margin has declined in the last couple of years.
HZO has a better Operating Margin (5.00%) than 66.67% of its industry peers.
In the last couple of years the Operating Margin of HZO has grown nicely.
HZO has a Gross Margin of 32.41%. This is in the lower half of the industry: HZO underperforms 61.67% of its industry peers.
In the last couple of years the Gross Margin of HZO has grown nicely.
Industry RankSector Rank
OM 5%
PM (TTM) N/A
GM 32.41%
OM growth 3Y-19.61%
OM growth 5Y1.53%
PM growth 3Y-40.71%
PM growth 5Y-11.66%
GM growth 3Y1.03%
GM growth 5Y4.78%
HZO Yearly Profit, Operating, Gross MarginsHZO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1

2. Health

2.1 Basic Checks

HZO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
HZO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, HZO has more shares outstanding
The debt/assets ratio for HZO is higher compared to a year ago.
HZO Yearly Shares OutstandingHZO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HZO Yearly Total Debt VS Total AssetsHZO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 1.82 indicates that HZO is not a great score, but indicates only limited risk for bankruptcy at the moment.
HZO has a Altman-Z score (1.82) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.17 is on the high side and indicates that HZO has dependencies on debt financing.
HZO has a Debt to Equity ratio of 1.17. This is in the lower half of the industry: HZO underperforms 61.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF N/A
Altman-Z 1.82
ROIC/WACC0.42
WACC9.08%
HZO Yearly LT Debt VS Equity VS FCFHZO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.21 indicates that HZO should not have too much problems paying its short term obligations.
HZO has a Current ratio of 1.21. This is in the lower half of the industry: HZO underperforms 60.83% of its industry peers.
A Quick Ratio of 0.29 indicates that HZO may have some problems paying its short term obligations.
HZO's Quick ratio of 0.29 is on the low side compared to the rest of the industry. HZO is outperformed by 77.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.29
HZO Yearly Current Assets VS Current LiabilitesHZO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

HZO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -56.03%.
The Earnings Per Share has been growing slightly by 5.01% on average over the past years.
HZO shows a decrease in Revenue. In the last year, the revenue decreased by -5.78%.
The Revenue has been growing by 14.46% on average over the past years. This is quite good.
EPS 1Y (TTM)-56.03%
EPS 3Y-32.09%
EPS 5Y5.01%
EPS Q2Q%-67.55%
Revenue 1Y (TTM)-5.78%
Revenue growth 3Y5.62%
Revenue growth 5Y14.46%
Sales Q2Q%-13.27%

3.2 Future

The Earnings Per Share is expected to grow by 9.17% on average over the next years. This is quite good.
Based on estimates for the next years, HZO will show a small growth in Revenue. The Revenue will grow by 0.34% on average per year.
EPS Next Y-63.32%
EPS Next 2Y-6%
EPS Next 3Y9.17%
EPS Next 5YN/A
Revenue Next Year-6.7%
Revenue Next 2Y-1.57%
Revenue Next 3Y0.34%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HZO Yearly Revenue VS EstimatesHZO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
HZO Yearly EPS VS EstimatesHZO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 22.58, HZO is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of HZO indicates a somewhat cheap valuation: HZO is cheaper than 68.33% of the companies listed in the same industry.
HZO is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.40, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 13.62, which indicates a correct valuation of HZO.
68.33% of the companies in the same industry are more expensive than HZO, based on the Price/Forward Earnings ratio.
HZO is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.58
Fwd PE 13.62
HZO Price Earnings VS Forward Price EarningsHZO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HZO indicates a rather cheap valuation: HZO is cheaper than 89.17% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.93
HZO Per share dataHZO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)4.5
EPS Next 2Y-6%
EPS Next 3Y9.17%

0

5. Dividend

5.1 Amount

HZO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MARINEMAX INC

NYSE:HZO (10/17/2025, 8:18:56 PM)

After market: 25.52 0 (0%)

25.52

-0.45 (-1.73%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners94.73%
Inst Owner Change-0.02%
Ins Owners2.55%
Ins Owner Change7.49%
Market Cap547.66M
Analysts81.67
Price Target34.85 (36.56%)
Short Float %16.98%
Short Ratio8.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.16%
Min EPS beat(2)-59.12%
Max EPS beat(2)83.44%
EPS beat(4)2
Avg EPS beat(4)48.21%
Min EPS beat(4)-59.12%
Max EPS beat(4)189.48%
EPS beat(8)3
Avg EPS beat(8)6.98%
EPS beat(12)5
Avg EPS beat(12)4.55%
EPS beat(16)9
Avg EPS beat(16)9.43%
Revenue beat(2)1
Avg Revenue beat(2)-2.21%
Min Revenue beat(2)-12.47%
Max Revenue beat(2)8.06%
Revenue beat(4)1
Avg Revenue beat(4)-3.31%
Min Revenue beat(4)-12.47%
Max Revenue beat(4)8.06%
Revenue beat(8)4
Avg Revenue beat(8)-0.15%
Revenue beat(12)6
Avg Revenue beat(12)-0.01%
Revenue beat(16)8
Avg Revenue beat(16)-0.32%
PT rev (1m)1.49%
PT rev (3m)0.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-140.55%
EPS NY rev (1m)0%
EPS NY rev (3m)-59.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.09%
Valuation
Industry RankSector Rank
PE 22.58
Fwd PE 13.62
P/S 0.24
P/FCF N/A
P/OCF 51.8
P/B 0.58
P/tB 1.45
EV/EBITDA 4.93
EPS(TTM)1.13
EY4.43%
EPS(NY)1.87
Fwd EY7.34%
FCF(TTM)-2.5
FCFYN/A
OCF(TTM)0.49
OCFY1.93%
SpS108.12
BVpS43.83
TBVpS17.55
PEG (NY)N/A
PEG (5Y)4.5
Profitability
Industry RankSector Rank
ROA -1.08%
ROE -2.85%
ROCE 7.75%
ROIC 3.78%
ROICexc 4.06%
ROICexgc 5.57%
OM 5%
PM (TTM) N/A
GM 32.41%
FCFM N/A
ROA(3y)6.87%
ROA(5y)9.12%
ROE(3y)13.71%
ROE(5y)16.71%
ROIC(3y)9.69%
ROIC(5y)12.16%
ROICexc(3y)11.72%
ROICexc(5y)15.7%
ROICexgc(3y)16.73%
ROICexgc(5y)22.44%
ROCE(3y)16.44%
ROCE(5y)19.71%
ROICexcg growth 3Y-46.03%
ROICexcg growth 5Y-2.42%
ROICexc growth 3Y-44.7%
ROICexc growth 5Y-7.52%
OM growth 3Y-19.61%
OM growth 5Y1.53%
PM growth 3Y-40.71%
PM growth 5Y-11.66%
GM growth 3Y1.03%
GM growth 5Y4.78%
F-Score4
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF N/A
Debt/EBITDA 6.72
Cap/Depr 134.26%
Cap/Sales 2.77%
Interest Coverage 1.5
Cash Conversion 6.45%
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 0.29
Altman-Z 1.82
F-Score4
WACC9.08%
ROIC/WACC0.42
Cap/Depr(3y)198.93%
Cap/Depr(5y)172.82%
Cap/Sales(3y)2.58%
Cap/Sales(5y)1.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.03%
EPS 3Y-32.09%
EPS 5Y5.01%
EPS Q2Q%-67.55%
EPS Next Y-63.32%
EPS Next 2Y-6%
EPS Next 3Y9.17%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.78%
Revenue growth 3Y5.62%
Revenue growth 5Y14.46%
Sales Q2Q%-13.27%
Revenue Next Year-6.7%
Revenue Next 2Y-1.57%
Revenue Next 3Y0.34%
Revenue Next 5YN/A
EBIT growth 1Y-14.52%
EBIT growth 3Y-15.1%
EBIT growth 5Y16.21%
EBIT Next Year-13.84%
EBIT Next 3Y9.34%
EBIT Next 5YN/A
FCF growth 1Y82.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.35%
OCF growth 3YN/A
OCF growth 5YN/A